Day 2 highlights of the International Workshop on Non-Hodgkin Lymphoma 2015 meeting: Bortezomib, proteasome inhibitor, for B-cell lymphoma
John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a discussion with Wyndham Wilson, MD, PhD, of the National Cancer Institute, ...
Author: VJHemOnc
Added: 11/18/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Dentistry | Lymphoma | Non-Hodgkin's Lymphoma | Velcade | Workshops